175 related articles for article (PubMed ID: 31103493)
1. Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors.
Ding Y; Tang F; Xue X; Luo J; Hussain M; Huang Y; Wang Z; Jiang H; Tu Z; Zhang J
Bioorg Chem; 2019 Aug; 89():102870. PubMed ID: 31103493
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors.
Yang X; Cai S; Liu X; Chen P; Zhou J; Zhang H
Bioorg Med Chem; 2019 Apr; 27(8):1605-1618. PubMed ID: 30858027
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors.
Dong J; Pan X; Yang Y; Zhang G; Xiao Z; Liu Z
Eur J Med Chem; 2021 Nov; 223():113631. PubMed ID: 34147748
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors.
Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X
Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925
[TBL] [Abstract][Full Text] [Related]
5. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors.
Pan L; Zheng Q; Chen Y; Yang R; Yang Y; Li Z; Meng X
Eur J Med Chem; 2018 Sep; 157():423-436. PubMed ID: 30103191
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory investigation of niacin derivatives on metalloenzyme indoleamine 2,3-dioxygenase 1 for its immunomodulatory function.
Yan D; Xu J; Tan X
Metallomics; 2021 Feb; 13(3):. PubMed ID: 33638642
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.
Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X
Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
Zhou C; Lai F; Sheng L; Chen X; Li Y; Feng Z
Molecules; 2020 Mar; 25(6):. PubMed ID: 32210078
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Kong KM; Zhang JW; Liu BZ; Meng GR; Zhang Q
Bioorg Med Chem Lett; 2020 Feb; 30(4):126901. PubMed ID: 31882299
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors.
Cui G; Lai F; Wang X; Chen X; Xu B
Eur J Med Chem; 2020 Feb; 188():111985. PubMed ID: 31881488
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays.
Ge H; Mao L; Zhao J; Wang Y; Shi D; Yang X; Wang X; Liu H; Yao X
J Comput Aided Mol Des; 2021 May; 35(5):679-694. PubMed ID: 33905074
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
[TBL] [Abstract][Full Text] [Related]
16. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
Gao D; Li Y
Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors.
Serafini M; Torre E; Aprile S; Massarotti A; Fallarini S; Pirali T
Molecules; 2019 May; 24(10):. PubMed ID: 31096672
[TBL] [Abstract][Full Text] [Related]
18. Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's disease.
Lu X; He SY; Li Q; Yang H; Jiang X; Lin H; Chen Y; Qu W; Feng F; Bian Y; Zhou Y; Sun H
Bioorg Med Chem; 2018 May; 26(8):1665-1674. PubMed ID: 29475581
[TBL] [Abstract][Full Text] [Related]
19. Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.
Peng YH; Ueng SH; Tseng CT; Hung MS; Song JS; Wu JS; Liao FY; Fan YS; Wu MH; Hsiao WC; Hsueh CC; Lin SY; Cheng CY; Tu CH; Lee LC; Cheng MF; Shia KS; Shih C; Wu SY
J Med Chem; 2016 Jan; 59(1):282-93. PubMed ID: 26642377
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
